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ABSTRACT: The feral pig populations of  many 
countries continue to increase. Scientific studies 
on population size are scarce, while the num-
bers of  reported observations on presence of 
and damage caused by feral pigs are increasing. 
Feral pigs can carry and spread several diseases 
(including zoonotic), but African Swine Fever 
(ASF) is of  most concern. It is a highly transmis-
sible viral disease associated with an extremely 
high mortality rate. Since 2009 ASF has ap-
peared in several European countries, with cases 
being identified first among local feral pigs and 
consequently in domestic pig production units, 
indicating a clear linkage with the movement of 
the feral pig population and the spread of  the 
disease across national boundaries. Control of 
feral pig populations is currently under discus-
sion. Because massive culling raises questions of 
animal welfare and ethics, fertility control could 
represent an important and effective means to 
control feral pig populations. Contraceptive vac-
cines have been used with some degree of  success 
in many wild species because they are able to pro-
vide a long-term effect without any consequent 
health problems. However, extensive and effica-
cious use of  vaccines to control feral pig popula-
tions is not simple. The aim of this article was to 
review the progress in immunocontraception use 
in feral pigs, providing an account of  the current 
status and future perspectives.
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INTRODUCTION
Populations of feral pigs have been increasing 
during the last 20 yr (Tack, 2018). Because feral 
pigs reproduce intensively (Fernández-Llario, 
2004), live isolated and largely nocturnal lives 
(Lemel et al., 2003) and are able to migrate over 
long distances, it is very difficult to estimate popu-
lation sizes accurately (Vetter et al., 2015). In the 
state of Texas, the number of feral pigs is reported 
to range from 1 to 4 million (Timmons et  al., 
2012). Although not based on scientific studies, the 
number of observations and increase in reported 
damage suggest that the feral pig population is con-
tinuously growing and expanding (Timmons et al., 
2012). Ongoing increase in the feral pig population 
is also apparent in Europe (Massei et al., 2015). 
Recent reports show that the number of harvested 
feral pigs has consistently increased during the 
past decade throughout many European countries 
(Tack, 2018), while the number of hunters has re-
mained relatively stable or declined in most coun-
tries (Massei et al., 2015). Increasing incidence of 
mild winters, intensification of arboreal growth 
in forest areas, crop production, and compensa-
tory population responses of feral pigs to hunting 
pressure might also explain their population 
growth (Massei et al., 2015). Other than man, the 
most significant contributor to its mortality (pri-
marily through hunting or car accidents) (Morelle 
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et  al., 2013; Sprem et  al., 2013), the feral pig has 
few predators. The gray wolf is considered to be its 
main predator: a single wolf  can kill around 50 to 
80 feral pigs in a year (Heptner et al., 1988), and in 
National Park areas of Italy and Belarus, feral pigs 
are the wolf’s primary prey (Marsan and Mattioli, 
2013). Another issue of increasing conflict between 
feral pigs and humans is damage to agricultural 
crops (Bleier et al., 2012; Lombardini et al., 2017). 
Timmons et  al. (2012) reported that agriculture 
losses due to feral pigs are at least $52 million each 
year solely in the state of Texas. Moreover, feral 
pigs in most areas are not among the native species, 
may serve as a vehicle of transmission for infectious 
diseases to humans and domestic pigs. Swine hepa-
titis E virus (HEV) is a zoonotic agent and bears 
a close genomic resemblance to human HEV. The 
disease causes asymptomatic infection in swine and 
is a public health concern, causing acute hepatitis 
of varying severity in humans (Salines et al., 2017). 
Classical swine fever (CSF), which is still one of 
the main viral diseases of pigs (Pejsak et al., 2014) 
can be spread by feral pigs acting as the reservoir 
for the virus, as reported in Europe (Tack, 2018). 
Many other zoonotic diseases can affect feral pigs, 
including Pasteurellosis, hemorrhagic septicemia, 
tularemia, anthrax, and Brucella, and they can be 
carriers of several endo- and ectoparasites (Tack, 
2018). Among all the diseases that can be spread 
by feral pigs, African Swine Fever (ASF), which is 
a highly transmissible viral disease associated with 
an extremely high mortality rate (Galindo and 
Alonso, 2017), is of greatest concern. Starting from 
2009 ASF has appeared in several European coun-
tries, firstly in local feral pigs and consequently in 
production units of domestic pigs, showing a clear 
linkage with the movement of the feral pig popu-
lation and the spread of the disease between coun-
tries (Galindo and Alonso, 2017; Guinat et  al., 
2017). Due to sanitary legislation, when ASF is 
confirmed in a particular country it heavily affects 
the pork industry, causing huge losses of animals 
due enforced culling, mortality of infected animals 
and severe trade restrictions (Guinat et al., 2016). 
It is clear that in many areas the feral pig popu-
lation is reaching a level which increases conflicts 
with humans, poses an increasing risk for animal 
and human health, and possibly becomes a ser-
ious threat to the pork industry. This explains why 
control of feral pig populations is currently under 
discussion.
Because massive culling raises issues of animal 
welfare and ethics, fertility control could play an im-
portant and effective role in reduction of feral pig 
populations. Theoretical and empirical models on 
population dynamics of wildlife show that fertility 
control may be effective as much, or even more so, 
as culling to reduce population size (Bradford and 
Hobbs, 2008). Different traditional methods of fer-
tility control are available for some animal popula-
tions (zoo/farm/pets) as well as for humans, but have 
several limitations. In order to achieve efficacious 
administration, several repeated doses of contra-
ceptive are needed, making them unpractical for 
use in wildlife. Contraceptive vaccines could repre-
sent a valuable alternative to traditional contracep-
tives because they provide long-term effect without 
representing any health hazards (Kirkpatrick et al., 
2011; Naz and Saver, 2016). Immunocontraception 
has been tried successfully in several animal species 
with promising results (Table 1). Even if  100% suc-
cess in immunization of feral pigs were not feasible, 
all the successfully immunized feral pigs would play 
an indirect role in reducing the resources available 
to the entire feral pig population in a specific area, 
including the nonimmunized individuals. The aim 
of this article was to review the progress of immu-
nocontraception use in feral pigs, providing a re-
view of the current status and future perspectives.
EVALUATION OF POPULATION SIZE AND 
DYNAMICS
Feral pig populations may be difficult to 
monitor for size and dynamics, but an accurate 
estimate of them is needed if  efficacy of a contra-
ceptive vaccination is to be explored. The difficulty 
in monitoring is due to their preference for habi-
tats that are not easily accessed by human beings, 
such as forested (Boitani et  al., 1995) and moun-
tainous areas (Acevedo et al., 2006). Family groups 
in which growing piglets are represented may espe-
cially seek for shelter in inner forests, whereas adult 
males may be more prone to wander into the neigh-
boring human settlements (Guo et al., 2017).
Typically, feral pigs live in family-based small 
groups of 1 to 6 individuals that may differ in terms 
of genotype, geography, gender, age, and season 
(Massei et  al., 2015; Veličković et  al., 2016; Guo 
et al., 2017). Females live together with their piglets 
while adult males tend to be solitary for most of the 
year and form groups only for limited periods in 
autumn and winter (Fernandez-Llario et al., 1996; 
Rosell et al., 2004). For instance, infrared camera 
trap surveys may be utilized to evaluate fluctuations 
in size of subpopulations over seasons as well as 
gender- and age distributions (Guo et  al., 2017). 
Changes in environment, climate, and genetics may 
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contribute to the differences among populations 
on different continents. In China, groups seem to 
be smaller than in Europe, and there seems to be a 
lower proportion of piglets compared with young 
adults and adults. However, the sex ratio in China 
appears similar to that found in Europe (Fernandez-
Llario and Mateos-Quesada, 2003; Guo et  al., 
2017). These differences may at least partly be at-
tributed to the differences in methods used to de-
termine age. In Europe, age estimation has been 
based on teeth analysis (eruption, wear; Boitani 
et  al., 1995; Merta et  al., 2015; Fernandez-Llario 
and Mateos-Quesada, 2003), whereas the Chinese 
study utilized body size and striping of the back as 
indicators of age (Guo et al., 2017). Both invasive 
and noninvasive methods have been used for evalu-
ation of the size of feral pig populations. Sweitzer 
et al. (2000) described a mark-sighting approach in 
certain regions of California to estimating the size 
of the population. They trapped the pigs and sed-
ated them in order to mark them with color-coded 
ear tags. The benefit of this method appears to be a 
high frequency of successful sighting rate by auto-
mated cameras and additional information gath-
ered by the procedure, such as teeth examination, 
lactation and pregnancy status of females, sampling 
for genetic studies, and body condition (Sweitzer 
et al., 2000). Similar capture protocols were there-
after used to study the contribution of domestic 
pig breeds to the feral pig genome (Gongora et al., 
2003). Parenteral vaccinations could be combined 
with these methods involving capture of feral pigs, 
which would considerably increase the value of 
such a caption. Obvious downsides of these inva-
sive methods, however, include high costs, reduced 
animal welfare and limitations to the number of 
animals captured and therefore the representative-
ness of the samples. In a modern society, the inva-
sive methods of this kind are currently becoming 
less popular and always have to conform to ethical 
guidelines.
Noninvasive methods to evaluate the popula-
tion size and dynamics include camera trap surveys 
(Guo et  al., 2017). This approach involves com-
bination of the latest technology, such as infrared 
cameras and GPS signaling, in a way that does not 
involve capture of the animals or other invasive 
procedures. These kind of direct observations can 
be combined with those used by hunting clubs. In 
addition, methods involving simulations based on 
track counts, utilizing a triangular area of obser-
vation or a transect, as in the Formozov-Malyshev-
Pereleshin method (Keeping and Pelletier, 2014), 
may represent a valuable addition for improving 
overall accuracy of methods used to estimate popu-
lation size and dynamics.
In conclusion, there is a clear need to develop 
a reliable and reasonable way of estimating the size 
Table 1. Contraception methods in different species
Species
Method of contraception and common 
route of administration Related references
Feral pig (Sus scrofa) GnRH vaccine, intramuscular injection Massei et al., 2012; Bevins et al., 2014
Cattle (Bos taurus/Bos 
indicus)
GnRH vaccine, intramuscular injection Massei et al., 2015
Horse (Equus caballus) GnRH vaccine, intramuscular injection 
PZP vaccine, intramuscular injection
Gray et al., 2010; Nuñez et al., 2017
Dog (Canis lupus 
familiaris)
GnRH agonist implant, subcutaneous 
administration 
Chemosterilants, testicular injection 
GnRH vaccine, intramuscular injection
Bertschinger et al., 2002; Herbert et al., 2005; Wang 2002; 
Massei et al., 2013; Rhodes 2017
Cat (Felis catus) Cabergoline, oral administration by bait 
GnRH vaccine, intramuscular injection
Munson et al., 2001, Bertschinger et al., 2002; Herbert et al., 
2005; Munson et al., 2006 
Jöchle and Jöchle, 1993; Robbins et al., 2004; Levy et al., 
2005; Levy 2011; Rhodes 2017.
Elephant (Ioxodonta 
Africana)
PZP vaccine, intramuscular injection Fayrer-Hosken et al.,1999
Bison (Bison bison) GnRH vaccine, intramuscular injection 
PZP vaccine, intramuscular injection
Miller et al., 2004; Duncan et al., 2017
Deer (Odocoileus 
virginianus)
PZP vaccine, intramuscular injection Turner et al., 1992, 1996
Elk (Cervus elaphus) PZP vaccine, intramuscular injection Kirkpatrick et al., 1996
Ground squirrel 
(Spermophilus 
beecheyi)
GnRH vaccine, intramuscular injection Yoder et al., 2011
GnRH, gonadotropin-releasing hormone; PZP, porcine zona pellucida.
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of  the population in a region of interest. This is the 
key issue when assessing the efficacy of different 
types of vaccines—otherwise one will never be able 
to determine if  the vaccine is effective or not. The 
traditional invasive, capture-recapture methods 
used for population size evaluation appear complex 
and not very useful for wild pigs. Instead, the nonin-
vasive methods incorporating the latest technology, 
direct observations and track counting based mod-
eling appear currently to be the most valuable, espe-
cially if  used in combination to improve accuracy.
IMMUNOCONTRACEPTION IN FERAL PIGS
Two different types of molecule have been stud-
ied as targets for development of contraceptive 
vaccines in animals, including pigs. These are either 
the regulators of gamete production, like gonado-
tropin-releasing hormone, follicle-stimulating hor-
mone and luteinizing hormone, or the regulators 
of gamete function, such as sperm-specific antigens 
and zona pellucida proteins. In pigs, the 2 major 
molecules that have been extensively investigated 
as principal antigens for immunocontraception are 
the gonadotropin-releasing hormone (GnRH) and 
the proteins of the zona pellucida.
GNRH VACCINES
Gonadotropin-releasing hormone peptides are 
produced in the hypothalamus and released in a 
pulsatile manner, leading to stimulation of the pitu-
itary gland and thereby release of gonadotrophins, 
LH and FSH (Millar et al., 2004). Because LH and 
FSH stimulate ovulation in females and spermato-
genesis in males, GnRH is an excellent contracep-
tive target to be used for both males and females. 
GnRH is a nonimmunogenic peptide and it must 
be conjugated to a carrier protein to make it im-
munogenic (Meeusen et al., 2007). There are many 
GnRH vaccines approved for wild and domestic 
animals (Miller et al., 2008; Boedeker et al., 2012; 
Table 1), and one is specifically registered for do-
mestic pigs with the main aim of preventing boar 
taint in males to be slaughtered (Dunshea et  al., 
2001). This vaccine could be used with a similar 
degree of success in feral pigs, if  a successful and 
inexpensive way of administration were found. 
In domestic pigs, this vaccine consists of 2 injec-
tions to induce a temporary contraceptive and 
consequently a reduction in boar taint expressing 
factors (androstenone and skatole) in intact male 
pigs (Dunshea et  al., 2001). According to Killian 
et al. (2006), injection of different titers of GnRH 
vaccine to male and female feral pigs stimulated 
different immune responses: females developed 
higher titers of specific antibodies with a 2,000-μg 
dose, and males had higher titers with a 1,000-μg 
dose. A  single intramuscular injection of a spe-
cific gonadotropin-releasing hormone vaccine de-
signed for use in wild animals (GonaCon, National 
Wildlife Research Center, Fort Collins, Colorado) 
successfully induced infertility in male (Campbell 
et al., 2010) and female (Killian et al., 2006) feral 
pigs. Gonadotropin-releasing hormone vaccination 
decreases the number of estrous cycles in females, 
which contrasts with porcine zona pellucida (PZP) 
vaccination, which increases the number of cyc-
ling females (Miller et al., 2000). However, GnRH 
vaccines do not cause any undesired health effects 
in males or females (Dunshea et  al., 2001; Curtis 
et al., 2008). Interestingly, vaccinated animals were 
in better body condition than unvaccinated ones 
(Gionfriddo et al., 2011), which could be connected 
with improved feed conversion ratio in immunized 
pigs (Dunshea et al., 2001).
ZONA PELLUCIDA VACCINES
In mammals, the female gamete is surrounded 
by a proteic membrane known as the zona pellucida 
(ZP). Zona pellucida glycoproteins are involved in 
species-specific sperm-egg binding, and protect the 
oocyte before implantation (Harris et  al., 1994). 
Raising antibodies against these ovum protein re-
ceptors for sperm can be used to inhibit fertilization. 
The use of PZP was the initial choice for vaccine 
development because porcine oocytes are obtained 
easily from slaughterhouses (Naz and Saver, 2016). 
This type of vaccine (PZP) has been used at least 
in horses, elephants, bison, deer, and elk (Table 1). 
Although the amounts of individual ZP compo-
nents differ among different species, some dimers 
of the sequence are conserved among mammalian 
species, thus enabling PZP to be efficiently used in 
other species (Stetson et  al., 2012). In many spe-
cies, intramuscular injections of raw porcine ZP 
protein (ZPZ) caused the female to raise antibodies 
against the sperm receptors on the ovum, effectively 
inhibiting fertilization (Kirkpatrick and Turner, 
1991). Currently there are many PZP vaccines on 
the market to be used for domestic, farm, zoo and 
wild animals (Naz and Saver, 2016; Table 1). Porcine 
zona pellucida vaccines have been confirmed to be 
reversible in mares and deer, if  vaccinated once 
or multiple times with variable time to regain fer-
tility (1 to 6 yr) (Miller et al., 2000; Kirkpatrick and 
Turner, 2002). The formulation and dose of PZP 
varies greatly among studies, ranging from 50 to 
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600 μg (Naz and Saver, 2016). Infertility and PZP 
antibody titers are closely correlated, when titers 
exceed a certain threshold the animals become in-
fertile and when titers revert, the individual regains 
its fertility (Liu et al., 1989). However, there are few 
studies on the efficacy of PZP vaccine in feral pigs.
FUTURE PERSPECTIVES FOR 
IMMUNOCONTRACEPTION IN FERAL PIGS
The most common contraceptive vaccines 
available have shown good efficacy in feral pigs, but 
all need to be administered intramuscularly. This 
is not an issue in animals that can be readily han-
dled (farms, zoo, natural reserves). In free-roaming 
wildlife, including feral pigs, however, handling is 
not feasible. Even remote delivery of the antigen 
with dart or biobullet is not practical because of 
the wide spread of feral pig populations, their 
nocturnal nature, and rapid movements. Darting 
would be similar to a hunting situation, in order 
to escape human chasing, the feral pig population 
would move faster in the area, increasing the risk of 
driving feral pigs into more distant areas. It would 
be of great advantage if  the vaccine could be ad-
ministered orally. Oral vaccination is scarcely used 
in animals and humans, with the exception of the 
oral polio vaccine, mainly because it requires larger 
quantities of antigen and the immune response is 
less predictable than with injections (Miller et al., 
1998). There are some successful experiences of 
using an oral vaccination against a pathogen in 
wildlife in conjunction with a viral disease outbreak. 
One such positive example is the outbreak of rabies 
in Finland in 1988 to 1989, in which the disease was 
found in some domestic species (cat, dog, and cow) 
and wildlife like the raccoon dog population, the red 
foxes, and the badgers. A highly successful oral vac-
cination campaign involving these wild species was 
mounted soon after the detection of the outbreak. 
Finland was declared free from the disease only 1 
to 2 yr after the outbreak, due to the successful vac-
cination campaign (Nyberg et al., 1992). The oral 
vaccine used was based on Tübingen Fox Baits con-
sisting of fat and fish meal, each containing 1.8 mL 
live attenuated SAD-B19 rabies virus in a plas-
tic-tinfoil capsule (Nyberg et  al., 1992). The baits 
contained tetracycline as a biomarker. In the first 
phase of vaccination, the baits were distributed by 
hunters on an area of 2,400 km2 and in a later phase 
by air distribution over an area of 225 km2. The up-
take of the baits were monitored both by observ-
ing the baits directly (species recognized by tooth 
marks in a proportion of cases) and by detection 
of the tetracycline biomarker in animals brought 
to autopsy (Nyberg et al., 1992). The main target 
of oral vaccination in mammals is the mucosal 
immune system, including the tonsils, and the im-
mune follicles of the small intestine, such as Peyer’s 
patches (Mestecky and McGhee, 1989). When tar-
geting the intestinal Peyer’s patches, the antigens 
(proteins) should be protected from stomach di-
gestion; therefore, immunization of the pharyngeal 
area is more feasible (Miller et al., 1999). In the last 
2 decades, understanding of the mechanisms used 
by viruses and bacteria to colonize the intestinal 
tract has opened new possibilities for developing 
successful and safe oral vaccines. Bacteriophage 
viruses have stimulated interest as possible carriers 
of specific antigens to be presented to the host to 
induce adaptive immune responses and humoral 
and/or cell-mediated immunity (Aghebati-Maleki 
et al., 2016). Bacteriophages are able to infect and 
replicate in bacteria but are not pathogenic to ani-
mals, including humans. Bacteriophages are stable 
in the gastrointestinal tract and thus increase their 
potential use as carriers for oral vaccines (Bazan 
et  al., 2012). The immunostimulatory effects of 
phage-based vaccines via oral administration were 
confirmed in various species (Delmastro et  al., 
1997; Ren et  al., 2008). To act as vaccines, phage 
particles can be re-engineered genetically or modi-
fied chemically to carry desirable antigenic domains 
(Samoylova et al., 2017). A hypothetical immuno-
contraception oral vaccine for feral pigs would need 
to be distributed in uncontrolled environments. 
Therefore, it might be taken up also by nontarget 
species, which renders species-specific preparations 
preferable (Samoylova et al., 2012). Samoylova et al. 
(2017) suggested that next-generation sequencing is 
a powerful tool that has the potential to accelerate 
and improve isolation of target-specific phages from 
phage display libraries. Although bacteriophages 
are viruses that specifically infect bacterial cells, a 
range of convincing evidence strongly supports the 
idea that these prokaryotic viruses can also deliver 
their encoded genes into mammalian cells.
In conclusion, phage-based preparations have 
already proved to be immunogenic after oral ad-
ministration (Delmastro et  al., 1997; Zuercher 
et al., 2000; Ren et al., 2008), indicating a realistic 
opportunity to develop practical contraceptive vac-
cines for use in feral pigs. It is evident that in the 
near future there will be a potential for effective 
contraceptive vaccines to be used in controlling 
overpopulation of feral pigs. However, more inves-
tigative efforts and resources should be allocated to 
identify and exploit possible immunocontraception 
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methods based on bacteriophage platforms, in 
order to develop a species-specific vaccine for feral 
pigs that is both efficacious and safe to use.
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